Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfeng Zhu

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cancer Cell|October 28, 2022
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapyKeyu Li, Joseph A Tandurella, Jessica Gai, et al.
Iscience|January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trialJanelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockadeDaniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Science (New York, N.Y.)|June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockadeSneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
The New England Journal of Medicine|October 14, 2022
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery OcclusionTudor G Jovin, Chuanhui Li, Longfei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Nature Immunology|October 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinomaDaniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Journal for Immunotherapy of Cancer|March 8, 2019
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer|February 13, 2019
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cancer Cell|October 28, 2022
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapyKeyu Li, Joseph A Tandurella, Jessica Gai, et al.
Iscience|January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trialJanelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockadeDaniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Science (New York, N.Y.)|June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockadeSneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
The New England Journal of Medicine|October 14, 2022
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery OcclusionTudor G Jovin, Chuanhui Li, Longfei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Nature Immunology|October 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinomaDaniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Journal for Immunotherapy of Cancer|March 8, 2019
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer|February 13, 2019
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Pageof 12